GLC Medical (GLCM) Inc.

"Health through Technology"

GLC Medical (GLCM) Inc. is a subsidiary company of Graphene Leaders Canada (GLC) Inc. and is a Canadian medical technology company engaged in the business of virus detection medical devices and rapid testing for specified viruses to be identified. The company is also exploring the application of graphene in its virus detection systems.

Who are we?

Following the spread of this global pandemic, GLC Medical (GLCM) Inc. was founded to carry out the research, product development and commercialization of our GLCM Biosensor Platform. 

The GLCM Biosensor Test Platform, which produces results in under one-minute, can be tailored to detect multiple viruses and other pathogens and represents a global breakthrough in medical diagnostics by providing real-time virus detection that is unmatched in terms of sensitivity, simplicity, and reproducibility by utilizing electrochemical impedance spectroscopy (EIS).  Successful implementation of the EIS method, which has been researched over decades as a desirable method of testing, is a breakthrough for GLCM and the medical diagnostics industry.

GLCM is investing heavily on further research and development for pioneering graphene applications in Health Innovation. 

Our latest project

GLCM Biosensor Test for COVID-19 and Variant

SARS-CoV-2 (COVID-19) is the first virus developed on the GLCM platform, which offers a non-invasive point-of-care, saliva-based diagnostic device which detects COVID-19 and all of its variants. 

Future developments on the platform include, but are not limited to, Tuberculosis, RSV (Respiratory Syncytial Virus), HIV, Malaria, Zika, with the potential to test for cancer markers. As this platform allows for fast testing solutions, GLCM believes it can contribute greatly to the goal of reducing the impact of future pandemics on people and world economies.

COVID-19 has been a life-changing event throughout the world, and the pandemic continues to be a major focus for governments, businesses, and industry as they adjust strategies to minimize the spread and resulting impacts on economies.  Rapid and reliable testing, like GLCM’s Biosensor Test and platform, remains critical in mitigating COVID’s economic impacts. 

In The News

Check out our latest news posting and publications.

Looking for more?

We are expanding the global economy. This technology is available to license and will be a monumental product for future generations.
Integratable modules allow our technology to communicate with microelectronics. This can be utilized for real-time updates and relaying data to human resource managers and health associations.
GLC Medical is currently seeking strategic partners and welcomes all inquiries and discussions relating to the advancement of this breakthrough virus detection technology.
For more information, please email us at glcmsolutions@glcplus.com